Itafos Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Itafos ha aumentado sus beneficios a una tasa media anual de 64.8%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 24.9% anual. Los ingresos han ido creciendo a una tasa media de 13.6% al año. La rentabilidad financiera de Itafos es de 1.2%, y sus márgenes netos son de 0.8%.

Información clave

64.8%

Tasa de crecimiento de los beneficios

66.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	4.5%
Tasa de crecimiento de los ingresos	13.6%
Rentabilidad financiera	1.2%
Margen neto	0.8%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Mar 29

Recent updates

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Feb 18

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Dec 17

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Itafos. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSXV:IFOS Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	466	4	28
30 Sep 23	482	81	28
30 Jun 23	524	86	28
31 Mar 23	563	110	27
31 Dec 22	593	115	29
30 Sep 22	575	109	29
30 Jun 22	525	117	29
31 Mar 22	473	82	33
31 Dec 21	413	51	26
30 Sep 21	372	17	24
30 Jun 21	316	-12	23
31 Mar 21	275	-43	19
31 Dec 20	260	-63	19
30 Sep 20	267	-141	21
30 Jun 20	301	-148	24
31 Mar 20	342	-149	27
31 Dec 19	339	-144	27
30 Sep 19	359	-211	26
30 Jun 19	353	-204	25
31 Mar 19	317	-178	22
31 Dec 18	302	-113	22
30 Sep 18	202	34	23
30 Jun 18	125	39	21
31 Mar 18	58	27	21
31 Dec 17	0	-30	19
30 Sep 17	0	-63	19
30 Jun 17	0	-101	16
31 Mar 17	0	-103	13
31 Dec 16	0	-101	10
30 Sep 16	0	-76	7
30 Jun 16	0	-75	5
31 Mar 16	0	-79	5
31 Dec 15	0	-118	6
30 Sep 15	0	-111	3
30 Jun 15	0	-84	5
31 Mar 15	0	-78	6
31 Dec 14	0	-29	7
30 Sep 14	0	-31	9
30 Jun 14	0	-18	9
31 Mar 14	0	-29	10
31 Dec 13	0	-32	12
30 Sep 13	1	-23	12
30 Jun 13	4	-24	14

Ingresos de calidad: IFOS tiene un gran one-off loss de $66.0M impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: Los actuales márgenes de beneficio(0.8%) de IFOS son inferiores a los del año pasado (19.4%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: IFOS ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 64.8% al año.

Acelerando crecimiento: IFOS ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: IFOS tuvo un crecimiento negativo de los beneficios (-96.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-53.6%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de IFOS (1.2%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Itafos Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

Actualizaciones de resultados anteriores recientes

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Recent updates

Itafos Inc., Annual General Meeting, Jun 19, 2024

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Provides Earnings Guidance for the Year 2023

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Itafos Files Updated Feasibility Study for the Farim Phosphate Project

Itafos Inc. Completes Updated Feasibility Study for the Farim Phosphate Project

Consensus EPS estimates increase by 16%

Itafos Inc., Annual General Meeting, Jul 13, 2023

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 22%

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Price target decreased to CA$5.25

Investor sentiment deteriorated over the past week

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improved over the past week

Consensus EPS estimates increase by 17%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Appoints Matthew O’Neill as Chief Financial Officer Succeeding George Burdette

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Itafos Inc. Announces Production and Sales of Hydrofluorosilicic Acid at Conda

Investor sentiment improved over the past week

Itafos Inc. Provides Earnings Guidance for the First Half and Second Half of 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Less than half of directors are independent

Itafos Inc., Annual General Meeting, Jun 24, 2022

Itafos Inc. Announces Board Changes

Itafos Inc. Announces Resumption of Sulfuric Acid Production at Arraias

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS US$0.05 (vs US$0.11 loss in 2Q 2020)

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.10 loss in 1Q 2020)

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Full year 2020 earnings released: US$0.34 loss per share (vs US$1.02 loss in FY 2019)

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Itafos Appoints David Brush as Chief Strategy Officer

Itafos(TSXV:IFOS) dropped from S&P/TSX Venture Composite Index

New 90-day high: CA$0.52

Itafos Announces Notice of Intent for Conda Mine Life Extension

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Itafos Announces Executive Changes

New 90-day low: CA$0.24

Analysts update estimates

Earnings released

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Desglose de ingresos y gastos
Beta